Sinovac Biotech Ltd. is a China-based biopharmaceutical company specialising in the research, development, production, and commercialisation of vaccines that protect against various human infectious diseases. The company focuses on providing innovative solutions to combat significant health challenges, with a broad product portfolio that includes vaccines for COVID-19, enterovirus 71-infected Hand-Foot-Mouth disease, hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Biologics
– Vaccine production
– Research and development

Sinovac Biotech Ltd. is dedicated to advancing global public health through its extensive vaccine offerings and is committed to delivering high-quality biopharmaceutical products. To learn more, please visit sinovac.com.